康芝药业: 第六届监事会第十六次会议决议公告

Group 1 - The company held its 16th meeting of the 6th Supervisory Board on June 6, 2025, in Haikou, where all three supervisors attended, meeting legal requirements [1] - The Supervisory Board approved the reappointment of Zhongshun Zhonghuan Accounting Firm as the company's auditing institution for the year 2025, with an audit fee of 720,000 yuan, and for internal control auditing at 280,000 yuan [1] - The appointment period for the auditing firm is one year, effective from the approval date at the 2024 annual general meeting [1] Group 2 - The proposal for the reappointment of the auditing firm will be submitted for review at the 2024 annual general meeting [2] - The company plans to purchase liability insurance for directors, supervisors, and senior management to enhance its risk management system and reduce operational risks [2] - The review process for the liability insurance proposal complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [2]